Join
Live feed
·
INSIDERFilingvia Quantisnow
Tempest Therapeutics Inc. logo

President and CEO Brady Stephen R bought $73,850 worth of shares (35,000 units at $2.11), increasing direct ownership by 308% to 46,376 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TPST· Tempest Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TPST (Tempest Therapeutics Inc.) and more on Quantisnow.